XML 29 R3.htm IDEA: XBRL DOCUMENT

Award Timing Disclosure

12 Months Ended

Dec. 31, 2025

Feb. 05, 2025

USD ($)

$ / shares

Award Timing Disclosures [Line Items]

The Company provides the following discussion of the timing of option awards in relation to the disclosure of material nonpublic

information, as required by Item 402(x) of Regulation S-K. We have adopted a granting policy covering all stock awards (including stock

options), both off-cycle (including hire-on) and ongoing annual grants. Under the policy, stock awards are granted by the Compensation

and Human Capital Committee, subject to approval by the Board in the case of grants to non-employee directors, and approval by the

independent directors of the Board in the case of grants to the Chief Executive Officer. Generally, the granting of stock awards occurs

on a pre-determined schedule, as described below. The Compensation and Human Capital Committee has delegated to the Chief

Executive Officer the authority to make "off-cycle grants" to new employees as a result of the acquisition of another company, in

situations where we are seeking to attract a senior level hire or recognize an employee for significant achievements or in other special

circumstances. In 2025 we made off-cycle grants to new hires, including those who became employees as a result of an acquisition,

and to select employees to recognize significant achievements and create retention incentives. Annual limits for off-cycle grants are

defined both per individual employee (20,000 shares) and in the aggregate (300,000 shares), with shares issuable in connection with

awards other than stock options being counted against such limits as 2.86 shares under our 2011 Long-Term Incentive Plan, as

amended or restated from time to time (the "2011 Plan").

The fair market value of Stryker stock used to establish the exercise price of all options is the closing sales price per share as reported

for NYSE Composite Transactions for the last trading day prior to the grant date. No stock grant is backdated and the timing of the

public release of material information or the grant of any stock award is not established with the intent of unduly benefiting a grantee

under a stock award. The Compensation and Human Capital Committee and, with respect to the Chief Executive Officer’s stock

awards, the independent directors of the Board, do not take material nonpublic information into account when determining the timing

and terms of stock awards. Instead, the timing of grants is in accordance with the compensation cycle described below. Each annual

grant and off-cycle grant of equity-based compensation is awarded on a pre-determined date as follows:

•The annual grant of stock awards for employees is generally made on the date of the February meeting of the Board. The annual

grant of stock awards for non-employee directors is generally made on the date of the Board meeting that coincides with our

annual meeting of shareholders. Any change in the annual grant date for employees or non-employee directors must be made

with the prior approval of the Board.

•Off-cycle awards may be granted by the Chief Executive Officer, pursuant to delegated authority from the Compensation and

Human Capital Committee, on or around the first business day of May, August or November following the date of hire or the

determination that an award is warranted in other circumstances. Off-cycle awards are reported to the Compensation and

Human Capital Committee and the Board at their next regular meetings.

The stock awards to our NEOs have historically included performance stock units, stock options, and occasionally, restricted stock

units. Where permissible by law, we require U.S. employees who receive stock awards to sign a version of the Company's

confidentiality, non-competition and non-solicitation agreement. The terms and conditions of our stock awards include recoupment

provisions that are applicable in the event of a violation of the non-compete agreement to which each of our NEOs has agreed.

The Company has not timed the disclosure of material nonpublic information to affect the value of executive compensation. Any

coordination between a grant of stock awards and the release of information that could be expected to affect such grant’s value is

generally precluded by the granting policy and pre-determined schedule, using the methodology described above.

The information in the table below is provided in accordance with Item 402(x)(2) of Regulation S-K regarding the grant of stock options

in 2025 within four business days before, or within one business day after, the filing of a report on Forms 10-K, 10-Q, or 8-K disclosing

material nonpublic information. The stock options included in the table were granted on February 5, 2025 as part of the annual grant of

stock awards, which occurred within four business days of the Form 8-K that was filed on February 10, 2025 that disclosed the details

of a public debt offering.


Name	Grant Date	Number of Securities Underlying Award (#)	Exercise Price ($/sh)	Grant Date Fair Value ($)	Percentage Change in the Closing Market Price of the Securities Underlying the Award Between the Trading Day Ending Immediately Prior to the Disclosure of Material Nonpublic Information and the Trading Day Beginning Immediately Following the Disclosure of Material Nonpublic Information
Kevin A. Lobo	2/5/2025	48,936	392.39	6,920,781	(0.2)%
Preston W. Wells	2/5/2025	9,176	392.39	1,297,717	(0.2)%
Spencer S. Stiles	2/5/2025	13,458	392.39	1,903,300	(0.2)%
J. Andrew Pierce	2/5/2025	13,458	392.39	1,903,300	(0.2)%
Viju S. Menon	2/5/2025	8,258	392.39	1,167,889	(0.2)%

Award Timing Method

The Company has not timed the disclosure of material nonpublic information to affect the value of executive compensation. Any

coordination between a grant of stock awards and the release of information that could be expected to affect such grant’s value is

generally precluded by the granting policy and pre-determined schedule, using the methodology described above.

Award Timing Predetermined

true

Award Timing MNPI Considered

true

Award Timing, How MNPI Considered

The Company has not timed the disclosure of material nonpublic information to affect the value of executive compensation. Any

coordination between a grant of stock awards and the release of information that could be expected to affect such grant’s value is

generally precluded by the granting policy and pre-determined schedule, using the methodology described above.

MNPI Disclosure Timed for Compensation Value

false

Awards Close in Time to MNPI Disclosures, Table

The information in the table below is provided in accordance with Item 402(x)(2) of Regulation S-K regarding the grant of stock options

in 2025 within four business days before, or within one business day after, the filing of a report on Forms 10-K, 10-Q, or 8-K disclosing

material nonpublic information. The stock options included in the table were granted on February 5, 2025 as part of the annual grant of

stock awards, which occurred within four business days of the Form 8-K that was filed on February 10, 2025 that disclosed the details

of a public debt offering.


Name	Grant Date	Number of Securities Underlying Award (#)	Exercise Price ($/sh)	Grant Date Fair Value ($)	Percentage Change in the Closing Market Price of the Securities Underlying the Award Between the Trading Day Ending Immediately Prior to the Disclosure of Material Nonpublic Information and the Trading Day Beginning Immediately Following the Disclosure of Material Nonpublic Information
Kevin A. Lobo	2/5/2025	48,936	392.39	6,920,781	(0.2)%
Preston W. Wells	2/5/2025	9,176	392.39	1,297,717	(0.2)%
Spencer S. Stiles	2/5/2025	13,458	392.39	1,903,300	(0.2)%
J. Andrew Pierce	2/5/2025	13,458	392.39	1,903,300	(0.2)%
Viju S. Menon	2/5/2025	8,258	392.39	1,167,889	(0.2)%